HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 8 analysts with an average price target of $44.94. This is a potential upside of $13.03 (6.47%) from yesterday's end of day stock price of $42.21.

Harmony Biosciences Holdings's activity chart (see below) currently has 159 price targets and 178 ratings on display. The stock rating distribution of HRMY is 83.33% BUY, 4.17% SELL and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.42% with an average time for these price targets to be met of 120.62 days.

Highest price target for HRMY is $62, Lowest price target is $28, average price target is $44.94.

Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 05-Aug-2026. First documented stock forecast 11-Sep-2020.

Best performing analysts who are covering HRMY - Harmony Biosciences Holdings:

David Amsellem Ami Fadia Graig Suvannavejh Chris Howerton Danielle Brill

Currently out of the existing stock ratings of HRMY, 20 are a BUY (83.33%), 1 are a SELL (4.17%), 3 are a HOLD (12.5%).

Split History since 2000:

12/5/00 3 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-May-2026

$34

$-7.52 (-18.11%)

$29

1 months 11 days ago
(05-Aug-2026)

8/14 (57.14%)

$-4.24 (-11.09%)

148

Buy Since 22-Sep-2021

$50

$8.48 (20.42%)

$44

1 months 12 days ago
(04-Aug-2026)

7/33 (21.21%)

$11.22 (28.93%)

302

Buy Since 01-Sep-2022

$51

$9.48 (22.83%)

$46

1 months 16 days ago
(31-Jul-2026)

17/33 (51.52%)

$15.76 (44.72%)

276

Hold Since 30-Jun-2026

$36

$-5.52 (-13.29%)

$47

2 months 17 days ago
(30-Jun-2026)

1/5 (20%)

$-0.41 (-1.13%)

1

Buy Since 17-Dec-2024

$55

$19.53 (55.06%)

$55

6 months 22 days ago
(25-Feb-2026)

0/12 (0%)

$26.81 (95.10%)

Show more analysts

Please expand the browser size to see the chart

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 121 days for the stock forecasts to be reached, with an average price target met ratio of 35.42%.

Which analyst most recently updated their price target on HRMY (Harmony Biosciences Holdings)?

Danielle Brill

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Danielle Brill works at TRUIST and has 9 price targets and 11 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Chris Howerton with the highest potential upside of $32.11

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Jason Gerberry with the lowest potential downside of -$13.52

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?